{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:26:43Z","timestamp":1793755603897,"version":"4.6.1"},"reference-count":135,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2025ZD01905903"],"award-info":[{"award-number":["2025ZD01905903"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jhepr.2026.102029","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:21:50Z","timestamp":1789453310000},"page":"102029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic liver disease-related osteoporosis: From mechanisms to precision intervention"],"prefix":"10.1016","volume":"8","author":[{"given":"Wenjing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9975-7042","authenticated-orcid":false,"given":"Guangyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burhan","family":"Yokus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiqiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7036-8108","authenticated-orcid":false,"given":"Pal","family":"Pacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8577-0527","authenticated-orcid":false,"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2026.102029_bib1","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/jgh.16982","article-title":"Incidence of osteopenia or osteoporosis in Asian patients with chronic hepatitis B","volume":"40","author":"Lee","year":"2025","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.102029_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jot.2024.07.008","article-title":"Emerging role of liver-bone axis in osteoporosis","volume":"48","author":"Gao","year":"2024","journal-title":"J Orthop Translat"},{"key":"10.1016\/j.jhepr.2026.102029_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12876-025-03720-6","article-title":"Prevalent osteoporosis and fracture risk in patients with hepatic cirrhosis: a systematic review and meta-analysis","volume":"25","author":"Shirinezhad","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhepr.2026.102029_bib4","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2147\/CLEP.S168237","article-title":"Liver disease and mortality among patients with hip fracture: a population-based cohort study","volume":"10","author":"Montomoli","year":"2018","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jhepr.2026.102029_bib5","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/CORR.0000000000002088","article-title":"Hip fractures in patients with liver cirrhosis: worsening liver function is associated with increased mortality","volume":"480","author":"Hundersmarck","year":"2022","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jhepr.2026.102029_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2024-100136","article-title":"New dimension in viral hepatitis research","volume":"2","author":"Cocca","year":"2024","journal-title":"eGastroenterology"},{"key":"10.1016\/j.jhepr.2026.102029_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2025-100196","article-title":"Key takeaways from the updated multidisciplinary European MASLD guidelines","volume":"3","author":"Horn","year":"2025","journal-title":"eGastroenterology"},{"key":"10.1016\/j.jhepr.2026.102029_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176345","article-title":"Alcohol-associated liver disease","volume":"134","author":"Mackowiak","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2026.102029_bib9","article-title":"Causal associations between osteoporosis and HBV infection across Asian and European populations: evidence from Mendelian randomization and colocalization analysis","volume":"15","author":"Li","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jhepr.2026.102029_bib10","article-title":"Association between chronic hepatitis B virus infection and risk of osteoporosis: a nationwide population-based study","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhepr.2026.102029_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1237618","article-title":"Association between resolved hepatitis B virus infection and femoral and spinal bone mineral density in American adults: a cross-sectional study","volume":"14","author":"Yang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jhepr.2026.102029_bib12","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12072-015-9672-7","article-title":"Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008-2010 Korea National Health and Nutrition Examination Surveys","volume":"10","author":"Baeg","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2026.102029_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13206152","article-title":"Association between chronic hepatitis B\/C and incidence of osteoporosis and bone fractures: results from a retrospective cohort study","volume":"13","author":"Loosen","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhepr.2026.102029_bib14","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/jbmr.4862","article-title":"Nonalcoholic fatty liver disease is associated with decreased bone mineral density in adults: a systematic review and meta-analysis","volume":"38","author":"Su","year":"2023","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jhepr.2026.102029_bib15","doi-asserted-by":"crossref","first-page":"1717852","DOI":"10.3389\/fendo.2025.1717852","article-title":"Association of metabolic dysfunction-associated steatotic liver disease with bone health in adults: a systematic review and meta-analysis of observational studies","volume":"16","author":"Li","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jhepr.2026.102029_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40618-023-02130-3","article-title":"Micro-scale vertebral features in postmenopausal women with alcohol-associated and metabolic-associated fatty liver disease: ex vivo bone quality analyses","volume":"47","author":"Jadzic","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jhepr.2026.102029_bib17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/jbmr\/zjaf065","article-title":"Site-specific alterations of bone matrix mineralization, micro-hardness, and density of mineralized osteocyte lacunae in men with alcohol-associated liver disease: implications for vertebral fracture predilection","volume":"40","author":"Jadzic","year":"2025","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jhepr.2026.102029_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.14309\/ajg.0000000000002354","article-title":"Increased risk of osteoporotic fracture in patients with autoimmune hepatitis","volume":"119","author":"Lim","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2026.102029_bib19","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/jbmr.4289","article-title":"Bone microarchitecture in patients with autoimmune hepatitis","volume":"36","author":"Schmidt","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jhepr.2026.102029_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12072-022-10461-1","article-title":"Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease","volume":"17","author":"Barchetta","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2026.102029_bib21","doi-asserted-by":"crossref","first-page":"1278505","DOI":"10.3389\/fendo.2023.1278505","article-title":"Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia\/osteoporosis in T2DM patients","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jhepr.2026.102029_bib22","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.4314\/ahs.v20i4.13","article-title":"Association between osteoporosis and hepatitis B cirrhosis: a case-control study","volume":"20","author":"Zhang","year":"2020","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.jhepr.2026.102029_bib23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cgh.2019.05.043","article-title":"A system to determine risk of osteoporosis in patients with autoimmune hepatitis","volume":"18","author":"Schmidt","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2026.102029_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/00365521.2022.2114813","article-title":"Bone disease in patients with cirrhosis of different etiology and severity; are Klotho protein and osteoprotegerin potential biomarkers?","volume":"58","author":"Katsaounis","year":"2023","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhepr.2026.102029_bib25","article-title":"Risk factors for osteoporosis in liver cirrhosis patients measured by transient elastography","volume":"97","author":"Zheng","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhepr.2026.102029_bib26","article-title":"Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2026.102029_bib27","doi-asserted-by":"crossref","DOI":"10.4103\/ajim.ajim_3_24","article-title":"Bone mineral density in chronic liver disease patients: high prevalence of osteopenia and osteoporosis in patients of advanced cirrhosis","volume":"13","author":"Koul","year":"2025","journal-title":"APIK J Intern Med"},{"key":"10.1016\/j.jhepr.2026.102029_bib28","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0174","article-title":"Increased risk of non-alcoholic fatty liver disease fibrosis is closely associated with osteoporosis in women but not in men with type 2 diabetes","volume":"11","author":"Yu","year":"2022","journal-title":"Endocr Connect"},{"key":"10.1016\/j.jhepr.2026.102029_bib29","first-page":"563","article-title":"Hepatic osteodystrophy in cirrhosis due to alcohol-related liver disease","volume":"113","author":"Pereira","year":"2021","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.jhepr.2026.102029_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clnesp.2025.07.002","article-title":"Impact of alcohol consumption and muscle mass on bone mineral density in metabolic dysfunction and alcohol-associated liver disease (MetALD) and metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"69","author":"Yokoyama","year":"2025","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.jhepr.2026.102029_bib31","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.clnu.2024.04.034","article-title":"Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: a cross-sectional study at a health examination center","volume":"43","author":"Yokoyama","year":"2024","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jhepr.2026.102029_bib32","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jhep.2023.12.001","article-title":"Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B","volume":"80","author":"Yip","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.102029_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102235","article-title":"Epigenetic regulations of cellular senescence in osteoporosis","volume":"99","author":"Huo","year":"2024","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.jhepr.2026.102029_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2023.101782","article-title":"Bone health and menopause: osteoporosis prevention and treatment","volume":"38","author":"de Villiers","year":"2024","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2026.102029_bib35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrendo.2013.171","article-title":"Osteoporosis in men","volume":"9","author":"Walsh","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jhepr.2026.102029_bib36","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/JOE-16-0089","article-title":"Influence of body weight on bone mass, architecture and turnover","volume":"230","author":"Iwaniec","year":"2016","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jhepr.2026.102029_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001383","article-title":"Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts","volume":"10","author":"Vimaleswaran","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.jhepr.2026.102029_bib38","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.4254\/wjh.v7.i9.1258","article-title":"Bone changes in alcoholic liver disease","volume":"7","author":"Gonz\u00e1lez-Reimers","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhepr.2026.102029_bib39","article-title":"MetALD: clinical aspects, pathophysiology and treatment","volume":"7","author":"Gratac\u00f3s-Gin\u00e8s","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2026.102029_bib40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s12276-024-01157-7","article-title":"Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases","volume":"56","author":"Takegahara","year":"2024","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jhepr.2026.102029_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179193","article-title":"RANK-RANKL-OPG Axis in MASLD: current evidence linking bone and liver diseases and future perspectives","volume":"25","author":"Monti","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2026.102029_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12102292","article-title":"The pathogenetic role of RANK\/RANKL\/OPG signaling in osteoarthritis and related targeted therapies","volume":"12","author":"Di Cicco","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jhepr.2026.102029_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236506","article-title":"Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer","volume":"15","author":"Yoo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2026.102029_bib44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ymthe.2024.12.046","article-title":"The p53-miR17 family-Rankl axis bridges liver-bone communication","volume":"33","author":"Ma","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.jhepr.2026.102029_bib45","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.12669\/pjms.36.6.2678","article-title":"Association of serum osteoprotegerin with severity of chronic liver disease in female patients: a potential biomarker","volume":"36","author":"Tariq","year":"2020","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.jhepr.2026.102029_bib46","article-title":"Changes in serum bone metabolism markers after living donor liver transplantation (LDLT) and their association with fracture occurrences","volume":"13","author":"Kuo","year":"2023","journal-title":"Life-Basel"},{"key":"10.1016\/j.jhepr.2026.102029_bib47","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.metabol.2015.12.005","article-title":"Plasma osteoprotegerin levels are inversely associated with nonalcoholic fatty liver disease in patients with type 2 diabetes: a case-control study in China","volume":"65","author":"Niu","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jhepr.2026.102029_bib48","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cmet.2015.09.010","article-title":"A liver-bone endocrine relay by IGFBP1 promotes osteoclastogenesis and mediates FGF21-induced bone resorption","volume":"22","author":"Wang","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2026.102029_bib49","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nrendo.2013.67","article-title":"The GH\/IGF-1 axis in ageing and longevity","volume":"9","author":"Junnila","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jhepr.2026.102029_bib50","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2022.02.006","article-title":"Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression","volume":"34","author":"Lu","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhepr.2026.102029_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108783","article-title":"7-ketocholesterol enhances autophagy via the ROS-TFEB signaling pathway in osteoclasts","volume":"96","author":"Sul","year":"2021","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.jhepr.2026.102029_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/endocrines6020019","article-title":"Cholesterol and bone resorption: yet another link between the bone and cardiovascular systems","volume":"6","author":"Klein","year":"2025","journal-title":"Endocrines"},{"key":"10.1016\/j.jhepr.2026.102029_bib53","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.bioactmat.2025.08.039","article-title":"Liver-bone organoids reveal senescence-driven interorgan crosstalk","volume":"54","author":"Zhang","year":"2025","journal-title":"Bioactive Mater"},{"key":"10.1016\/j.jhepr.2026.102029_bib54","doi-asserted-by":"crossref","first-page":"821-+","DOI":"10.1038\/s42255-023-00803-0","article-title":"SIRT2 regulates extracellular vesicle-mediated liver-bone communication","volume":"5","author":"Lin","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhepr.2026.102029_bib55","first-page":"570","article-title":"Liver-bone organoids reveal senescence-driven interorgan crosstalk","volume":"54","author":"Zhang","year":"2025","journal-title":"Bioact Mater"},{"key":"10.1016\/j.jhepr.2026.102029_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106943","article-title":"Bile acid metabolism regulatory network orchestrates bone homeostasis","volume":"196","author":"Xiang","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jhepr.2026.102029_bib57","article-title":"Increased concentrations of conjugated bile acids are associated with osteoporosis in PSC patients","volume":"12","author":"St\u00fcrznickel","year":"2022","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.jhepr.2026.102029_bib58","first-page":"119","article-title":"FOS\/GOS attenuates high-fat diet induced bone loss via reversing microbiota dysbiosis, high intestinal permeability and systemic inflammation in mice","author":"Zhang","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.jhepr.2026.102029_bib59","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2437250","article-title":"Alterations of gut virome with close interaction in the progression of estrogen deficiency-induced osteoporosis","volume":"16","author":"Chen","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jhepr.2026.102029_bib60","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2593088","article-title":"Gut microbiota preserves bone mass through modulating the hyodeoxycholic acid-TGR5 axis","volume":"17","author":"Zheng","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jhepr.2026.102029_bib61","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.biopha.2018.08.093","article-title":"Activation of TGR5 promotes osteoblastic cell differentiation and mineralization","volume":"108","author":"Wang","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jhepr.2026.102029_bib62","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/jbmr.3652","article-title":"Dual targeting of bile acid receptor-1 (TGR5) and farnesoid X receptor (FXR) prevents estrogen-dependent bone loss in mice","volume":"34","author":"Li","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jhepr.2026.102029_bib63","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146619","article-title":"From the gut to bone: connecting the gut microbiota with Th17 T lymphocytes and postmenopausal osteoporosis","volume":"131","author":"Lorenzo","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2026.102029_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1497311","article-title":"Mechanisms of gut homeostasis regulating Th17\/Treg cell balance in PMOP","volume":"15","author":"Qi","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2026.102029_bib65","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s40001-025-02702-4","article-title":"Identification of the pyroptosis, apoptosis, and necroptosis (PANoptosis) involved in osteogenic differentiation inhibition impaired by tumor necrosis factor-\u03b1","volume":"30","author":"Xia","year":"2025","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jhepr.2026.102029_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/cells14161264","article-title":"Comparison of primary human osteoblast-like cells and hFOB 1.19 cells: contrasting effects of proinflammatory cytokines","volume":"14","author":"Bousch","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.jhepr.2026.102029_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.836764","article-title":"Understanding reactive oxygen species in bone regeneration: a glance at potential therapeutics and bioengineering applications","volume":"10","author":"Sheppard","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jhepr.2026.102029_bib68","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-023-05595-5","article-title":"PINK1\/Parkin-mediated mitophagy inhibits osteoblast apoptosis induced by advanced oxidation protein products","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhepr.2026.102029_bib69","article-title":"Isoquercitrin attenuates the osteoclast-mediated bone loss in rheumatoid arthritis via the Nrf2\/ROS\/NF-\u03baB pathway","volume":"1870","author":"Liu","year":"2024","journal-title":"Biochimica et Biophysica Acta (BBA) - Mol Basis Dis"},{"key":"10.1016\/j.jhepr.2026.102029_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116880","article-title":"Advanced glycation and glycoxidation end products in bone","volume":"176","author":"Wang","year":"2023","journal-title":"Bone"},{"key":"10.1016\/j.jhepr.2026.102029_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043772","article-title":"Oxidative stress and inflammation in osteoporosis: molecular mechanisms involved and the relationship with microRNAs","volume":"24","author":"Iantomasi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2026.102029_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043772","article-title":"Oxidative stress and inflammation in osteoporosis: molecular mechanisms involved and the relationship with microRNAs","volume":"24","author":"Iantomasi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2026.102029_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810705","article-title":"The role of vitamin D and vitamin D binding protein in chronic liver diseases","volume":"23","author":"Pop","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2026.102029_bib74","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.26488","article-title":"Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients","volume":"58","author":"Farnik","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.102029_bib75","doi-asserted-by":"crossref","first-page":"135","DOI":"10.14218\/JCTH.2017.00055","article-title":"Vitamin D deficiency and its relationship with child-pugh class in patients with chronic liver disease","volume":"6","author":"Jamil","year":"2018","journal-title":"J Clin Transl Hepato"},{"key":"10.1016\/j.jhepr.2026.102029_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117108","article-title":"Secondary hyperparathyroidism: predictors and relationship with vitamin D status, bone turnover markers and bone mineral density","volume":"184","author":"Fitzpatrick","year":"2024","journal-title":"Bone"},{"key":"10.1016\/j.jhepr.2026.102029_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1734","article-title":"KMT2A and chronic inflammation as potential drivers of sporadic parathyroid adenoma","volume":"14","author":"Xu","year":"2024","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jhepr.2026.102029_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212139","article-title":"Primary osteoporosis induced by androgen and estrogen deficiency: the molecular and cellular perspective on pathophysiological mechanisms and treatments","volume":"25","author":"Hsu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2026.102029_bib79","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMcp2307353","article-title":"Postmenopausal osteoporosis","volume":"389","author":"Walker","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2026.102029_bib80","article-title":"Testosterone delays bone microstructural destruction via osteoblast-androgen receptor-mediated upregulation of tenascin-C","volume":"12","author":"Xie","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jhepr.2026.102029_bib81","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5385","article-title":"Obesity and lipid metabolism in the development of osteoporosis (Review)","volume":"54","author":"Wang","year":"2024","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jhepr.2026.102029_bib82","article-title":"Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover","volume":"23","author":"Cheng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2026.102029_bib83","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","article-title":"EASL Clinical Practice Guidelines on nutrition in chronic liver disease","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.102029_bib85","unstructured":"International Osteoporosis Foundation Diagnosis. https:\/\/www.osteoporosis.foundation\/health-professionals\/diagnosis. Accessed 2 Apr 2026."},{"key":"10.1016\/j.jhepr.2026.102029_bib86","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.dld.2025.01.133","article-title":"Bone fragility and fracture risk assessment in metabolic disfunction-associated steatotic liver disease","volume":"57","author":"Asero","year":"2025","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2026.102029_bib87","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jbmr\/zjae194","article-title":"Romosozumab improves microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis","volume":"40","author":"McClung","year":"2025","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jhepr.2026.102029_bib88","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.matpr.2020.02.833","article-title":"Bone fracture risk: density and microarchitecture qualification","volume":"32","author":"Cosmi","year":"2020","journal-title":"Mater Today Proc"},{"key":"10.1016\/j.jhepr.2026.102029_bib89","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s43166-024-00252-x","article-title":"Update on the utility of trabecular bone score (TBS) in clinical practice for the management of osteoporosis: a systematic review by the Egyptian Academy of Bone and Muscle Health","volume":"51","author":"El Miedany","year":"2024","journal-title":"Egypt Rheumatol Rehabil"},{"key":"10.1016\/j.jhepr.2026.102029_bib90","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jbmr.4739","article-title":"Teriparatide followed by denosumab in premenopausal idiopathic osteoporosis: bone microstructure and strength by HR-pQCT","volume":"38","author":"Agarwal","year":"2023","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jhepr.2026.102029_bib91","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00198-025-07422-3","volume":"36","author":"Bhattoa","year":"2025","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jhepr.2026.102029_bib92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gene.2018.08.074","article-title":"Serum miRNAs miR-140-3p and miR-23b-3p as potential biomarkers for osteoporosis and osteoporotic fracture in postmenopausal Mexican-Mestizo women","volume":"679","author":"Ram\u00edrez-Salazar","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.jhepr.2026.102029_bib93","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/CIA.S269171","article-title":"MicroRNA-197-3p inhibits the osteogenic differentiation in osteoporosis by down-regulating KLF 10","volume":"16","author":"You","year":"2021","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jhepr.2026.102029_bib94","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jare.2024.10.019","article-title":"Plasma proteomic profiles reveal proteins and three characteristic patterns associated with osteoporosis: a prospective cohort study","volume":"75","author":"Zheng","year":"2025","journal-title":"J Adv Res"},{"key":"10.1016\/j.jhepr.2026.102029_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11061542","article-title":"Physiological basis for using vitamin D to improve health","volume":"11","author":"Wimalawansa","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jhepr.2026.102029_bib96","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000827","article-title":"Denosumab versus zoledronic acid for osteoporosis treatment in patients with primary biliary cholangitis (the DELTA Study): a multicenter, non-inferiority randomized trial","volume":"9","author":"Arase","year":"2025","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2026.102029_bib97","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00198-025-07602-1","article-title":"Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis","volume":"36","author":"Ko","year":"2025","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jhepr.2026.102029_bib98","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.1016\/j.clbc.2017.11.010","article-title":"Prevention of tamoxifen-related nonalcoholic fatty liver disease in breast cancer patients","volume":"18","author":"Chang","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jhepr.2026.102029_bib99","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.breast.2016.04.017","article-title":"Clinical significance of fatty liver disease induced by tamoxifen and toremifene in breast cancer patients","volume":"28","author":"Yang","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.jhepr.2026.102029_bib100","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/liv.14434","article-title":"Prevalence, incidence and risk factors of tamoxifen-related non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"40","author":"Lee","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2026.102029_bib101","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11657-024-01447-7","article-title":"Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Li","year":"2024","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.jhepr.2026.102029_bib102","article-title":"Different effects of menopausal hormone therapy on non-alcoholic fatty liver disease based on the route of estrogen administration","volume":"13","author":"Kim","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2026.102029_bib103","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12951-024-02581-7","article-title":"Inflammatory microenvironment regulation and osteogenesis promotion by bone-targeting calcium and magnesium repletion nanoplatform for osteoporosis therapy","volume":"22","author":"Weng","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.jhepr.2026.102029_bib104","doi-asserted-by":"crossref","first-page":"35368","DOI":"10.1021\/acsnano.4c12064","article-title":"Receptor activator of nuclear factor kappa-B-expressing mesenchymal stem cells-derived extracellular vesicles for osteoporosis therapy","volume":"18","author":"Chang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jhepr.2026.102029_bib105","article-title":"Bone-targeted biomimetic nanogels Re-establish osteoblast\/osteoclast balance to treat postmenopausal osteoporosis","volume":"20","author":"Cui","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jhepr.2026.102029_bib106","doi-asserted-by":"crossref","first-page":"23955","DOI":"10.1021\/acsnano.5c05460","article-title":"Integration of bone-targeted delivery and crosstalk modulation of liver-bone Axis for improved osteoporosis therapy","volume":"19","author":"You","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jhepr.2026.102029_bib107","doi-asserted-by":"crossref","first-page":"10216","DOI":"10.1021\/acs.jmedchem.5c00394","article-title":"Identification of a RANKL\/TNF-\u03b1 dual-inhibitor as a potential disease-modifying agent for the treatment of knee osteoarthritis","volume":"68","author":"Shao","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.jhepr.2026.102029_bib108","article-title":"Tenofovir-induced osteopenia and hyperparathyroidism: a case report and literature review","volume":"13","author":"Zeng","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jhepr.2026.102029_bib109","article-title":"An in-depth investigation of NAs-induced osteoporosis adverse events: a real-world, network toxicology and molecular docking analysis","volume":"12","author":"Di","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jhepr.2026.102029_bib110","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/425079","article-title":"The role of serum cytokines in the pathogenesis of hepatic osteodystrophy in male cirrhotic patients","volume":"2012","author":"Soylu","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.jhepr.2026.102029_bib111","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.intimp.2017.02.019","article-title":"Th17\/Treg imbalance and increased interleukin-21 are associated with liver injury in patients with chronic severe hepatitis B","volume":"46","author":"Liu","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jhepr.2026.102029_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95640-0","article-title":"Increased frequency of Th17 cells and IL-17 levels are associated with low bone mineral density in postmenopausal women","volume":"11","author":"Bhadricha","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2026.102029_bib113","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI96139","article-title":"Insulin resistance causes inflammation in adipose tissue","volume":"128","author":"Shimobayashi","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2026.102029_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110691","article-title":"Association between obesity, inflammation and insulin resistance: insights into signaling pathways and therapeutic interventions","volume":"200","author":"Suren Garg","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jhepr.2026.102029_bib115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.biochi.2023.04.011","article-title":"Recent progress in leptin signaling from a structural perspective and its implications for diseases","volume":"212","author":"Fan","year":"2023","journal-title":"Biochimie"},{"key":"10.1016\/j.jhepr.2026.102029_bib116","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/stem.2520","article-title":"Chemokine-like receptor 1 is a novel wnt target gene that regulates mesenchymal stem cell differentiation","volume":"35","author":"Muruganandan","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.jhepr.2026.102029_bib117","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.102029_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68566-2","article-title":"Mitochondrial dysfunction impairs osteogenesis, increases osteoclast activity, and accelerates age related bone loss","volume":"10","author":"Dobson","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2026.102029_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1148814","article-title":"Epigallocatechin gallate alleviates high-fat diet-induced hepatic lipotoxicity by targeting mitochondrial ROS-mediated ferroptosis","volume":"14","author":"Ding","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhepr.2026.102029_bib120","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ajpath.2025.06.010","article-title":"Chronic alcohol consumption enhances the differentiation capacity of hematopoietic stem and progenitor cells into osteoclast precursors","volume":"196","author":"Hemati","year":"2026","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhepr.2026.102029_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12071515","article-title":"The effects of Acute and chronic alcohol administration and withdrawal on bone microstructure, mechanical strength, and remodeling protein expression and their relation to an antioxidant and FGF23 in vivo","volume":"12","author":"Syed Hashim","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jhepr.2026.102029_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.636231","article-title":"Gut microbiota is involved in alcohol-induced osteoporosis in young and old rats through immune regulation","volume":"11","author":"Cheng","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jhepr.2026.102029_bib123","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/toxsci\/kfab135","article-title":"Binge ethanol exposure in mice represses expression of genes involved in osteoblast function and induces expression of genes involved in osteoclast differentiation independently of endogenous catalase","volume":"185","author":"Denys","year":"2022","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jhepr.2026.102029_bib124","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s42255-021-00355-1","article-title":"How alcohol affects motor control: not your usual suspects","volume":"3","author":"Melani","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhepr.2026.102029_bib125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00223-025-01358-w","article-title":"Atractylenolide I attenuates glucocorticoid-induced osteoporosis via inhibiting NF-\u03baB signaling pathway","volume":"116","author":"Liu","year":"2025","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jhepr.2026.102029_bib126","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s10020-025-01169-7","article-title":"Metformin ameliorates osteoporosis by enhancing bone angiogenesis via the YAP1\/TAZ-HIF1\u03b1 axis","volume":"31","author":"Yin","year":"2025","journal-title":"Mol Med"},{"key":"10.1016\/j.jhepr.2026.102029_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092839","article-title":"Metformin attenuates osteoporosis in diabetic patients with carcinoma in situ: a nationwide, retrospective, matched-cohort study in Taiwan","volume":"9","author":"Lu","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhepr.2026.102029_bib128","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/s41419-024-07177-5","article-title":"Metformin improves HPRT1-targeted purine metabolism and repairs NR4A1-mediated autophagic flux by modulating FoxO1 nucleocytoplasmic shuttling to treat postmenopausal osteoporosis","volume":"15","author":"Yang","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhepr.2026.102029_bib129","article-title":"Use of GLP-1 receptor agonist and risk of osteoporosis among patients with type 2 diabetes: a real-world study","volume":"16","author":"Chen","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jhepr.2026.102029_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2025.112935","article-title":"SGLT2 inhibitor, bone metabolism biomarkers, and osteoporosis risk: a Mendelian randomization study","volume":"211","author":"Wang","year":"2025","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jhepr.2026.102029_bib131","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1186\/s12891-024-07900-5","article-title":"The effect of empagliflozin (sodium-glucose cotransporter-2 inhibitor) on osteoporosis and glycemic parameters in patients with type 2 diabetes: a quasi-experimental study","volume":"25","author":"Tan","year":"2024","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jhepr.2026.102029_bib132","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2026.4722","article-title":"GLP-1 receptor agonists and noncardiometabolic outcomes: an umbrella review of meta-analyses","volume":"9","author":"Yang","year":"2026","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jhepr.2026.102029_bib133","first-page":"914","article-title":"Pioglitazone and risk for bone fracture: safety data from a randomized clinical trial","volume":"102","author":"Viscoli","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jhepr.2026.102029_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112995","article-title":"Association of tirzepatide use with risk of osteoporosis compared with other GLP-1 receptor agonists: a retrospective cohort study using the TriNetX database","volume":"230","author":"Hsu","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jhepr.2026.102029_bib135","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afac255","article-title":"Acceptability and engagement amongst patients on oral and intravenous bisphosphonates for the treatment of osteoporosis in older adults","volume":"51","author":"Narayanasamy","year":"2022","journal-title":"Age and Ageing"},{"key":"10.1016\/j.jhepr.2026.102029_bib136","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s40674-024-00219-1","article-title":"Current treatment for glucocorticoid-induced osteoporosis: beyond bisphosphonates","volume":"10","author":"Humphrey","year":"2024","journal-title":"Curr Treat Options Rheumatol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926003009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926003009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:56:09Z","timestamp":1793753769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555926003009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":135,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2589555926003009"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.102029","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic liver disease-related osteoporosis: From mechanisms to precision intervention","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.102029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"102029"}}